# MODULE 15 — Mn OPTIONALITY SPECIFICATION
## FINAL FREEZE INTEGRITY CHECK

**Document ID:** `PS-VIVA-MOD15-FREEZE-CHECK-001`  
**Execution Date:** 2026-09-25  
**Auditor / Freeze Architect:** Forensic Runtime Auditor & Curriculum Architect  
**Audited Artifact:** `MODULE_15_MN_OPTIONALITY_ARCHITECTURE_SPEC.md` (`PS-VIVA-MOD15-SPEC-001-REV2`)  
**Supporting Logs:**  
- `MODULE_15_MN_OPTIONALITY_ARCHITECTURE_REPAIR_LOG.md` (`PS-VIVA-MOD15-REPAIR-LOG-001`)  
- `MODULE_15_MN_OPTIONALITY_FINAL_MICRO_REPAIR_LOG.md` (`PS-VIVA-MOD15-MICRO-LOG-001`)  
- `MODULE_15_MN_OPTIONALITY_ARCHITECTURE_POST_REPAIR_FORENSIC_AUDIT.md` (`PS-VIVA-MOD15-POST-AUDIT-001`)  
**Repository Target:** `indomethacin-asd-framework` (Commit `285c3d7`, Baseline `v1.5.0-FOUR-CRITERION-FREEZE`)  
**Viva School Modules:** Modules 00–14 (100% UNTOUCHED)  
**Classification:** Immutability, Diff, and Freeze Certification Check  
**Authorization Status:** READ-ONLY FREEZE AUDIT — ZERO MODIFICATIONS AUTHORIZED  

---

## 1. Final Specification Integrity

The presence, revision metadata, and structural completeness of all Module 15 deliverables were verified:

| Deliverable Artifact | File Path | File Size | Revision / Status | Verification Status |
| :--- | :--- | :---: | :---: | :---: |
| **Architectural Specification** | `MODULE_15_MN_OPTIONALITY_ARCHITECTURE_SPEC.md` | 51,944 bytes | `REV2` (`PS-VIVA-MOD15-SPEC-001-REV2`) | **PASS** |
| **Phase D Repair Log** | `MODULE_15_MN_OPTIONALITY_ARCHITECTURE_REPAIR_LOG.md` | 10,022 bytes | Certified (`PS-VIVA-MOD15-REPAIR-LOG-001`) | **PASS** |
| **Final Micro-Repair Log** | `MODULE_15_MN_OPTIONALITY_FINAL_MICRO_REPAIR_LOG.md` | 4,749 bytes | Certified (`PS-VIVA-MOD15-MICRO-LOG-001`) | **PASS** |
| **Post-Repair Forensic Audit** | `MODULE_15_MN_OPTIONALITY_ARCHITECTURE_POST_REPAIR_FORENSIC_AUDIT.md` | 22,098 bytes | Certified (`PS-VIVA-MOD15-POST-AUDIT-001`) | **PASS** |

* **Metadata Audit:** Line 5 of the specification explicitly declares `**Revision:** Phase D Final Micro-Repair (REV2)`. The document is structurally intact across all 19 defined sections.

---

## 2. Exact Diff Audit

A forensic line-by-line diff between the pre-micro-repair version (`REV1`) and the final frozen version (`REV2`) was conducted. The diff demonstrates that **only the two authorized micro-repairs** were introduced:

### **Repair A — $M_n$ Range Terminology Reconciliation:**
* **Pre-Micro-Repair Text (REV1, Section 8.1):**
  > *"Thermodynamic miscibility is chain-length dependent. Pointwise $\chi < \chi_c(M_n)$ holds for low-$M_n$ fractions ($M_n < M_n^*$) but fails for high-$M_n$ fractions ($M_n \ge M_n^*$). ... Miscibility sensitive to high-MW fraction."*
* **Final Frozen Text (REV2, Section 8.1):**
  > *"RANGE-INDETERMINATE: the diagnostic outcome depends on the actual $M_n$ value within the supplied $M_n$ interval. Pointwise $\chi < \chi_c(M_n)$ holds if the true $M_n$ is below the threshold $M_n^*$, but fails if the true $M_n$ is above $M_n^*$. UI Text: RANGE-INDETERMINATE: the diagnostic outcome depends on the actual Mn value within the supplied Mn interval (χc,min ≤ χ < χc,max)."*
* **Scope & Conformance:** References to "molecular weight distribution" in Cases 1 and 2 were cleanly aligned to "supplied $M_n$ interval". Zero mentions of "high-Mw tail", "distribution tail", or unsupported continuous distribution sensitivity remain.

### **Repair B — Provenance of $1.3\%$–$3.8\%$ Claim Reconciliation:**
* **Pre-Micro-Repair Text (REV1, Section 1.2 & Section 17.1):**
  > *"artificially depresses $\chi_c$ by $1.3\%$ to $3.8\%$ across reference polymers."*  
  > *"introduces an artificial negative bias of up to $3.8\%$ in $\chi_c$."*
* **Final Frozen Text (REV2, Section 1.2 & Section 17.1):**
  > *"artificially depresses $\chi_c$ by $1.34\%$ to $3.73\%$ (previously stated as $1.3\%$ to $3.8\%$) across the five reference polymers in `config/polymers/polymer_library_v3_five_polymers.csv`."*  
  > *"introduces an artificial negative bias of up to $3.73\%$ (previously stated as up to $3.8\%$) in $\chi_c$, as independently recalculated across the five reference polymers in `config/polymers/polymer_library_v3_five_polymers.csv`."*
* **Scope & Conformance:** Eliminates any implication of external literature publication. Grounded explicitly in repository data calculations.

* **Unauthorized Semantic Modifications:** **0 (ZERO)**.  
* **Audit Verdict:** `AUTHORIZED_DIFF_ONLY = YES`.

---

## 3. Mathematical Immutability Audit

The final specification was audited to ensure all active v2 mathematical equations remain 100% immutable and intact:

1. **Active Decision Matrix:** $\mathbf{S} = [s_{\text{HSP}},\; s_\chi,\; s_{\text{desc}},\; s_{\text{GT}}] \in [0, 1]^{N \times 4}$ — **PRESENT & UNALTERED**
2. **Standardization:** $Z = (S - \mu) / \sigma$ (population standard deviation, ddof=0) — **PRESENT & UNALTERED**
3. **Correlation Matrix:** $R = \frac{1}{n} Z^T Z \in \mathbb{R}^{4 \times 4}$ — **PRESENT & UNALTERED**
4. **$K$-Selection:** Variance-retention threshold rule (cumulative explained variance $\ge 95\%$) — **PRESENT & UNALTERED**
5. **Subspace Coordinates:** $T = Z V_K \in \mathbb{R}^{N \times K}$ — **PRESENT & UNALTERED**
6. **Subspace Metric Tensor:** $M_K = V_K^T W V_K \in \mathbb{R}^{K \times K}$ — **PRESENT & UNALTERED**
7. **Ideal / Anti-Ideal Points:** $z^+ = (1 - \mu) / \sigma, z^- = (0 - \mu) / \sigma$, $t^+ = z^+ V_K, t^- = z^- V_K \in \mathbb{R}^{1 \times K}$ — **PRESENT & UNALTERED**
8. **Quadratic Distances:** $D_i^\pm = \sqrt{(t_i - t^\pm)^T M_K (t_i - t^\pm)}$ — **PRESENT & UNALTERED**
9. **Closeness Coefficient:** $C_L = \frac{D_i^-}{D_i^+ + D_i^-}$ (or $C_{L,i}$) — **PRESENT & UNALTERED**
10. **Banned Formulations:** Zero occurrences of $W^{1/2}(I + \sum \lambda_k v_k v_k^T)W^{1/2}$ or unprojected formulations — **CONFIRMED EXCLUDED**
* **Audit Verdict:** `MATHEMATICAL_IMMUTABILITY = PASS`.

---

## 4. Mn Diagnostic Immutability Audit

1. **Exact Pointwise Comparator:**  
   The candidate diagnostic evaluates:
   $$\chi < \chi_c$$
   Strict inequality is preserved across 18 distinct references in the specification. Zero occurrences of $\chi \le \chi_c$ exist.
2. **First Derivative Proof:**  
   $$\frac{\partial \chi_c}{\partial M_n} = -\frac{1 + 1/\sqrt{r_2}}{2 r_2^{3/2} \rho_{\text{poly}} V_{\text{m,drug}}} < 0$$
   Strictly negative across the positive domain $(0, \infty)$.
3. **Bounding Interval Inversion:**  
   $$\chi_{c,\min} = \chi_c(M_{n,\max})$$
   $$\chi_{c,\max} = \chi_c(M_{n,\min})$$
   Preserved identically.
* **Audit Verdict:** `CHI_COMPARATOR_IMMUTABILITY = PASS`, `RANGE_LOGIC_IMMUTABILITY = PASS`.

---

## 5. Terminology Final Scan

An automated, whole-document scan was performed on `MODULE_15_MN_OPTIONALITY_ARCHITECTURE_SPEC.md` across all prohibited, ambiguous, or unsupported terms:

| Audit Search Term | Contextual Scan Requirement | Detected Count in Spec | Scan Verdict |
| :--- | :--- | :---: | :---: |
| `high-Mw tail` | Forbidden in diagnostic context | **0** | **PASS** |
| `distribution tail` | Forbidden in diagnostic context | **0** | **PASS** |
| `Euclidean TOPSIS` | Prohibited metric terminology | **0** | **PASS** |
| `eigengap as K-selection` | Prohibited functional confusion | **0** | **PASS** |
| `certified Mn` / `certified` | Forbidden without analytical standard | **0** | **PASS** |
| `r2 approx 1 classifier` | Forbidden invented domain classifier | **0** | **PASS** |
| `scientifically invalid` | Forbidden universal claim | **0** | **PASS** |
| `thermodynamically invalid` | Forbidden universal claim | **0** | **PASS** |
| `dual status` | Forbidden vague terminology | **0** | **PASS** |
| `C_i` | Deprecated closeness symbol | **0** | **PASS** |
| Gate 1 candidate exclusion | Prohibited functional claim | **0** | **PASS** |

* **Standardized Active Terminology Verified:**
  * Candidate level: **Flory-Huggins Phase-Boundary Diagnostic**
  * Cohort level: **HSP Cohort Feasibility Screen**
  * Criteria weights: **Decision-theoretic AHP preference weights**
  * Metric operator: **Positive-definite quadratic-form metric induced by physical AHP weighting in the retained PCA subspace**
* **Audit Verdict:** `TERMINOLOGY_FINAL = PASS`.

---

## 6. Epistemic Boundary Audit

The final specification strictly maintains the boundary between active facts and proposed target specifications:

* **Active Implementation Facts [A]:**
  * $M_n$ is absent from criteria $s_{\text{HSP}}, s_\chi, s_{\text{desc}}, s_{\text{GT}}$.
  * Comparator in `flory_huggins.py:23` is strict inequality ($\chi < \chi_c$).
  * Candidate diagnostic is non-exclusionary (Eudragit E PO ranked Rank 5).
  * API schema rejects $M_n \le 0$ with HTTP 422 `ValidationError`.
  * Counterfactual invariance $\Delta C_L = 0.000000$ verified under tested cohorts and tested conditions.
* **Authoritative Methodology Facts [B]:**
  * $K$-selection by cumulative variance threshold ($\ge 95\%$); eigengap $\Delta_K$ is post-selection stability diagnostic.
  * Metric tensor is $M_K = V_K^T W V_K \in \mathbb{R}^{K \times K}$.
  * $M_w$ substitution depresses $\chi_c$ by $1.34\%$ to $3.73\%$ across the 5 reference polymers.
* **Proposed Future Architecture [C]:**
  * `PolymerCreateV2` or version-gated schemas.
  * $M_n$ optionality for core MCDA workflows.
  * $M_n$ range support $[M_{n,\min}, M_{n,\max}]$.
  * Advanced provenance logging enums.
  * `NOT_APPLICABLE_NON_POLYMER` domain classifier (explicitly marked as a proposed future extension).
* **Unsupported Class D Claims:** **0 (ZERO)**.
* **Audit Verdict:** `EPISTEMIC_BOUNDARY = PASS`.

---

## 7. v1.5 / v2 Version Isolation Audit

The final specification explicitly enforces version boundaries:
* **v1.5 Frozen Contract:** Unchanged. Enforces mandatory $M_n$, strict Pydantic validation, and baseline 14-page PDF report.
* **v2 Optional-$M_n$ Contract:** Proposed future implementation. Relaxes $M_n$ for core MCDA while retaining diagnostic evaluation when supplied.
* **Architectural Mitigation:** Implementation file map designates version-branched API routing (`PolymerCreateV2`) and report generator branching on `engine_version == "v1.5.0-FOUR-CRITERION-FREEZE"`.
* **Epistemic Framing:** Phrased accurately as *"is designed to preserve"* and *"will require regression verification"*, with zero unwarranted claims of automatic regression guarantees.
* **Audit Verdict:** `V1_5_V2_ISOLATION = PASS`.

---

## 8. File-System & Source Integrity Audit

A git status and file-system audit confirmed:
* **Production Repository (`indomethacin-asd-framework`):** **0 files modified (100% UNTOUCHED)**.
* **Viva School Modules 00–14:** **0 files modified (100% UNTOUCHED)**.
* **Production Tests, Config, Releases:** **100% UNTOUCHED**.
* **Implementation Performed:** **NO (ZERO code changes, zero patches executed)**.
* **Intended Changed Artifacts Since Baseline:**
  * `MODULE_15_MN_OPTIONALITY_ARCHITECTURE_SPEC.md` (Specification)
  * `MODULE_15_MN_OPTIONALITY_ARCHITECTURE_REPAIR_LOG.md` (Phase D Repair Log)
  * `MODULE_15_MN_OPTIONALITY_FINAL_MICRO_REPAIR_LOG.md` (Final Micro-Repair Log)
  * `MODULE_15_MN_OPTIONALITY_ARCHITECTURE_POST_REPAIR_FORENSIC_AUDIT.md` (Post-Repair Audit)
* **Audit Verdict:** `FILE_SYSTEM_INTEGRITY = PASS`.

---

## 9. Micro-Repair Log Consistency Audit

The micro-repair log `MODULE_15_MN_OPTIONALITY_FINAL_MICRO_REPAIR_LOG.md` was audited against the specification:
* Accurately details Repair 1 (Range terminology) and Repair 2 (Provenance of 1.3%–3.8% claim).
* Accurately confirms that no mathematics, no input contracts, and no code implementation were altered.
* Matches the exact diff between `REV1` and `REV2`.
* **Audit Verdict:** `MICRO_REPAIR_LOG = PASS`.

---

## 10. Final Freeze Decision

```
================================================================================
             MODULE 15 FINAL FREEZE INTEGRITY CERTIFICATION
================================================================================
Target Artifact: MODULE_15_MN_OPTIONALITY_ARCHITECTURE_SPEC.md (REV2)
Target Status:   FORMALLY FROZEN & CERTIFIED

DECISION: MODULE_15_SPECIFICATION_FROZEN

SUMMARY SCORECARD:
- Exact Authorized Diff Only:     YES (0 unauthorized changes)
- Mathematical Immutability:      PASS (Exact v2 active equations)
- Flory-Huggins Comparator:       PASS (Strict inequality chi < chi_c)
- Range Logic Immutability:       PASS (Deterministic PASS, FAIL, RANGE-INDETERMINATE)
- Terminology Final Scan:         PASS (0 forbidden / misleading terms)
- Epistemic Boundary Check:       PASS (0 Class D claims remaining)
- v1.5 / v2 Version Isolation:    PASS (Explicit branching strategy)
- Micro-Repair Log Consistency:   PASS (100% cross-reconciled)
- File-System Source Integrity:   PASS (Production & Modules 00–14 untouched)

P0 Defects: 0
P1 Defects: 0
P2 Defects: 0
P3 Defects: 0

FINAL_STATUS = MODULE_15_SPECIFICATION_FROZEN
================================================================================
```
